Exor, a diversified holding company, completed the acquisition of a 10% stake in Merieux Alliance, a privately held global healthcare holding, for $894m. “We have long admired Institut Mérieux and the Mérieux family’s successful entrepreneurial culture combined with their passion to solve the most critical medical challenges. Our purpose is to build great companies and we are excited to contribute with Alain and Alexandre to accelerate Institut Mérieux’s growth. For us, this is a unique opportunity to enter the healthcare sector with a strong partner with whom we share the same values and long-term horizon,” John Elkann, Exor Chief Executive Officer.